Health NZ Approves Xofluza Purchase for National Reserve Supply

An exemption was approved by Health NZ directors in September 2024 for the purchase of approximately 40,000 courses of Xofluza for the National Reserve Supply (NRS) in New Zealand. This is a one-off purchase.

Source ID: NZ-GETS-31321250

Scope overview

An exemption was approved by Health NZ directors in September 2024 for the purchase of approximately 40,000 courses of Xofluza for the National Reserve Supply (NRS) in New Zealand. This is a one-off purchase.

Statusawarded
CategoryContract Award
CountryNew Zealand
Publish dateOct 29, 2024
Submission deadlineOct 29, 2024
Estimated value
Notice typeaward_notice
Sourcenz-gets-awards
BuyerHealth New Zealand (Te Whatu Ora)
City

Buyer & contacts

OrganizationHealth New Zealand (Te Whatu Ora)

Tags & Signals

Xofluza procurementNational Reserve SupplyHealth New Zealandantiviral medicationpandemic preparednessinfluenza treatmentpharmaceutical stockpileone-off purchase

Need alerts, export, or document OCR?

The tender record stays public. Those actions live in the private workspace.

Disclaimer: IndexBox Tenders does not issue, announce, or publish this tender. This information is aggregated from publicly available sources and is provided for informational purposes only. IndexBox Tenders is not affiliated with, endorsed by, or acting on behalf of the tender issuer. Users should verify all information directly with the official tender source before making any decisions or taking any action.